National Healthcare (NHC)
National Healthcare on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as services-skilled nursing care facilities.
755K
Short interest
settlement 2026-10-15
8.9
Days to cover
+2.8 days vs prior
70.5%
Short share of volume
2026-11-02
1,258
Fails to deliver
settlement 2026-09-28
Fri 6 Nov
Next earnings
estimated date
-$5.6M
Insider flow, 90 days
0 buys, 15 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in NHC is 755,039 shares, up 71,864 shares over the last month. Over the last 48 readings it ranged from 196,889 shares (30 May 2025) to 817,160 shares (30 September 2026). At the reported average volume of 85K shares a day that is 8.9 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/nhc" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 755,039 | -7.6% | 84,624 | 8.92 |
| 2026-09-30 | 817,160 | +19.6% | 132,770 | 6.15 |
| 2026-09-15 | 683,175 | -8.5% | 81,861 | 8.35 |
| 2026-08-31 | 746,799 | -1.3% | 102,929 | 7.26 |
| 2026-08-14 | 756,850 | +1.2% | 129,254 | 5.86 |
| 2026-07-31 | 747,974 | +4.9% | 102,613 | 7.29 |
| 2026-07-15 | 713,058 | -9.8% | 111,419 | 6.40 |
| 2026-06-30 | 790,113 | +42.9% | 223,641 | 3.53 |
| 2026-06-15 | 552,921 | -7.0% | 123,012 | 4.49 |
| 2026-05-29 | 594,600 | -6.5% | 111,519 | 5.33 |
| 2026-05-15 | 635,979 | -7.8% | 92,369 | 6.89 |
| 2026-04-30 | 690,101 | -9.8% | 128,950 | 5.35 |
| 2026-04-15 | 765,215 | +7.3% | 117,265 | 6.53 |
| 2026-03-31 | 713,361 | +22.7% | 154,338 | 4.62 |
| 2026-03-13 | 581,372 | +21.7% | 93,385 | 6.23 |
| 2026-02-27 | 477,852 | +14.2% | 88,060 | 5.43 |
| 2026-02-13 | 418,386 | +10.8% | 61,921 | 6.76 |
| 2026-01-30 | 377,645 | +11.8% | 60,480 | 6.24 |
| 2026-01-15 | 337,737 | -19.1% | 79,596 | 4.24 |
| 2025-12-31 | 417,491 | +27.9% | 105,701 | 3.95 |
| 2025-12-15 | 326,286 | +4.2% | 71,985 | 4.53 |
| 2025-11-28 | 313,105 | +2.9% | 70,609 | 4.43 |
| 2025-11-14 | 304,167 | +3.4% | 63,423 | 4.80 |
| 2025-10-31 | 294,240 | +1.2% | 60,314 | 4.88 |
| 2025-10-15 | 290,738 | -12.0% | 71,348 | 4.07 |
| 2025-09-30 | 330,307 | +27.2% | 123,714 | 2.67 |
| 2025-09-15 | 259,597 | +2.5% | 43,365 | 5.99 |
| 2025-08-29 | 253,311 | -0.4% | 35,650 | 7.11 |
| 2025-08-15 | 254,294 | -0.8% | 48,919 | 5.20 |
| 2025-07-31 | 256,485 | +2.9% | 56,822 | 4.51 |
| 2025-07-15 | 249,279 | -13.0% | 70,492 | 3.54 |
| 2025-06-30 | 286,537 | +10.0% | 109,218 | 2.62 |
| 2025-06-13 | 260,392 | +32.3% | 56,320 | 4.62 |
| 2025-05-30 | 196,889 | -11.0% | 33,827 | 5.82 |
| 2025-05-15 | 221,183 | -14.8% | 45,457 | 4.87 |
| 2025-04-30 | 259,600 | +1.4% | 43,029 | 6.03 |
| 2025-04-15 | 255,903 | -14.6% | 53,807 | 4.76 |
| 2025-03-31 | 299,752 | -6.2% | 90,041 | 3.33 |
| 2025-03-14 | 319,556 | -6.9% | 53,739 | 5.95 |
| 2025-02-28 | 343,194 | -0.7% | 67,468 | 5.09 |
| 2025-02-14 | 345,612 | -2.5% | 47,299 | 7.31 |
| 2025-01-31 | 354,317 | +2.9% | 59,832 | 5.92 |
| 2025-01-15 | 344,338 | -17.6% | 59,578 | 5.78 |
| 2024-12-31 | 417,833 | +14.2% | 64,913 | 6.44 |
| 2024-12-13 | 365,760 | +4.8% | 43,183 | 8.47 |
| 2024-11-29 | 349,083 | -4.6% | 40,128 | 8.70 |
| 2024-11-15 | 365,830 | +6.6% | 55,518 | 6.59 |
| 2024-10-31 | 343,188 | -7.2% | 36,705 | 9.35 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of NHC volume is 70.5%, down 3.3 points over the last five sessions. Over the last 30 readings it ranged from 46.3% (6 October 2026) to 88.5% (22 October 2026). The latest reading is 4.1 points below the 30-session average of 74.6%, on 64K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 45K | 64K | 70.5% | 136 |
| 2026-10-30 | 48K | 61K | 78.9% | 0 |
| 2026-10-29 | 34K | 54K | 62.4% | 0 |
| 2026-10-28 | 71K | 101K | 70.1% | 15 |
| 2026-10-27 | 49K | 70K | 70.4% | 0 |
| 2026-10-26 | 69K | 93K | 73.9% | 32 |
| 2026-10-23 | 27K | 36K | 74.7% | 9 |
| 2026-10-22 | 67K | 76K | 88.5% | 0 |
| 2026-10-21 | 28K | 37K | 74.9% | 0 |
| 2026-10-20 | 23K | 38K | 61.0% | 0 |
| 2026-10-19 | 42K | 51K | 82.3% | 0 |
| 2026-10-16 | 24K | 33K | 73.1% | 0 |
| 2026-10-15 | 29K | 38K | 77.2% | 0 |
| 2026-10-14 | 18K | 24K | 75.0% | 0 |
| 2026-10-13 | 15K | 18K | 80.3% | 172 |
| 2026-10-12 | 15K | 20K | 78.1% | 0 |
| 2026-10-09 | 17K | 20K | 86.2% | 0 |
| 2026-10-08 | 20K | 27K | 73.5% | 0 |
| 2026-10-07 | 17K | 21K | 80.6% | 0 |
| 2026-10-06 | 18K | 40K | 46.3% | 0 |
| 2026-10-05 | 31K | 36K | 86.5% | 0 |
| 2026-10-02 | 24K | 28K | 84.1% | 0 |
| 2026-10-01 | 24K | 32K | 73.8% | 0 |
| 2026-09-30 | 22K | 33K | 66.7% | 0 |
| 2026-09-29 | 27K | 34K | 77.6% | 0 |
| 2026-09-28 | 19K | 30K | 64.7% | 0 |
| 2026-09-25 | 34K | 49K | 70.1% | 0 |
| 2026-09-24 | 19K | 25K | 73.9% | 69 |
| 2026-09-23 | 29K | 34K | 84.7% | 32 |
| 2026-09-22 | 21K | 26K | 78.5% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 28 September 2026, the fails-to-deliver balance in NHC is 1,258 shares, up 696 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (18 June 2026) to 10,902 shares (18 May 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-28 | 1,258 | $227.36 | $286K |
| 2026-09-21 | 562 | $222.11 | $125K |
| 2026-08-18 | 21 | $228.20 | $5K |
| 2026-08-17 | 179 | $223.59 | $40K |
| 2026-08-14 | 14 | $219.84 | $3K |
| 2026-08-07 | 17 | $219.45 | $4K |
| 2026-08-04 | 45 | $222.76 | $10K |
| 2026-07-24 | 65 | $221.51 | $14K |
| 2026-07-22 | 27 | $222.85 | $6K |
| 2026-07-20 | 7 | $228.16 | $2K |
| 2026-07-17 | 319 | $224.64 | $72K |
| 2026-06-30 | 1,387 | $206.33 | $286K |
| 2026-06-29 | 215 | $206.54 | $44K |
| 2026-06-22 | 14 | $201.53 | $3K |
| 2026-06-18 | 3 | $191.10 | $573 |
| 2026-05-18 | 10,902 | $193.65 | $2.1M |
| 2026-05-13 | 722 | $189.47 | $137K |
| 2026-05-05 | 137 | $170.61 | $23K |
| 2026-04-02 | 74 | $157.97 | $12K |
| 2026-04-01 | 5,031 | $159.70 | $803K |
| 2026-03-23 | 91 | $158.81 | $14K |
| 2026-03-20 | 999 | $157.73 | $158K |
| 2026-03-10 | 3,492 | $160.52 | $561K |
| 2026-03-02 | 21 | $163.50 | $3K |
| 2026-02-13 | 213 | $168.33 | $36K |
| 2026-02-12 | 1,897 | $168.34 | $319K |
| 2025-12-22 | 6 | $141.64 | $850 |
| 2025-12-12 | 8 | $137.75 | $1K |
| 2025-11-24 | 584 | $130.44 | $76K |
| 2025-10-22 | 7 | $121.33 | $849 |
Insider trades
SEC Form 4, newest first. JSONInsiders at NHC reported 15 open-market sells worth $5.6M in the last 90 days and no open-market buys. Latest filing: Dodson Vicki L (Sr.VP Patient Srvcs) on 2026-09-22.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-22 | Dodson Vicki L | Sr.VP Patient Srvcs | Sell | 5K | $225.00 | $1.1M | 11K |
| 2026-09-11 | KIDD BRIAN F | SVP, CFO | Sell | 7K | $225.70 | $1.5M | 23K |
| 2026-09-10 | McCreary Josh A | Senior VP & General Counsel | Sell | 68 | $225.59 | $15K | 10K |
| 2026-09-10 | McCreary Josh A | Senior VP & General Counsel | Sell | 1K | $225.09 | $291K | 10K |
| 2026-09-10 | McCreary Josh A | Senior VP & General Counsel | Sell | 789 | $223.78 | $177K | 11K |
| 2026-09-10 | McCreary Josh A | Senior VP & General Counsel | Sell | 571 | $222.73 | $127K | 12K |
| 2026-08-28 | FLATT BEN ANDERSON SR | Senior VP & CIO | Sell | 1K | $222.50 | $223K | 16K |
| 2026-08-25 | FLATT BEN ANDERSON SR | Senior VP & CIO | Sell | 1K | $227.00 | $227K | 17K |
| 2026-08-25 | Gifford David R. | Director | Sell | 2K | $225.42 | $401K | 1K |
| 2026-08-20 | FLATT BEN ANDERSON SR | Senior VP & CIO | Sell | 1K | $237.00 | $237K | 18K |
| 2026-08-20 | Gifford David R. | Director | Grant | 5K | $236.75 | $1.1M | 3K |
| 2026-08-20 | Gifford David R. | Director | Exercise or conversion | 6K | $171.42 | $1.1M | 8K |
| 2026-08-19 | FLATT BEN ANDERSON SR | Senior VP & CIO | Sell | 1K | $237.18 | $237K | 19K |
| 2026-08-19 | Flatt Stephen Fowler | CEO | Sell | 2K | $237.08 | $356K | 65K |
| 2026-08-17 | FLATT BEN ANDERSON SR | Senior VP & CIO | Sell | 1K | $226.00 | $226K | 20K |
| 2026-08-14 | FLATT BEN ANDERSON SR | Senior VP & CIO | Sell | 1K | $222.11 | $222K | 21K |
| 2026-08-13 | Gifford David R. | Director | Exercise or conversion | 1K | $171.42 | $175K | 1K |
| 2026-08-12 | FLATT BEN ANDERSON SR | Senior VP & CIO | Sell | 1K | $221.21 | $221K | 22K |
| 2026-06-22 | HASSAN EMIL E | Director | Sell | 6K | $200.00 | $1.2M | 66K |
| 2026-06-16 | HASSAN EMIL E | Director | Sell | 2K | $199.98 | $313K | 72K |
| 2026-06-16 | KIDD BRIAN F | SVP, CFO | Gift | 500 | $0.00 | $0 | 30K |
| 2026-06-08 | ADAMS ROBERT G | Director | Gift | 4K | $0.00 | $0 | 14K |
| 2026-06-08 | ADAMS ROBERT G | Director | Exercise or conversion | 4K | $69.19 | $277K | 18K |
| 2026-06-01 | Piercey Lisa | Director | Buy | 949 | $184.26 | $175K | 949 |
| 2026-05-22 | FLATT BEN ANDERSON SR | Senior VP & CIO | Tax withholding | 3K | $196.00 | $537K | 23K |
| 2026-05-22 | FLATT BEN ANDERSON SR | Senior VP & CIO | Exercise or conversion | 4K | $94.10 | $376K | 25K |
| 2026-05-21 | LAROCHE RICHARD F JR | Director | Sell | 8K | $195.14 | $1.5M | 206K |
| 2026-05-20 | Flatt Stephen Fowler | CEO | Gift | 26 | $0.00 | $0 | 67K |
| 2026-05-19 | Shelly Timothy J. | Sr.VP Operations | Sell | 2K | $197.22 | $365K | 1K |
| 2026-05-14 | KIDD BRIAN F | SVP, CFO | Tax withholding | 3K | $197.96 | $620K | 30K |
| 2026-05-14 | KIDD BRIAN F | SVP, CFO | Exercise or conversion | 500 | $90.62 | $45K | 34K |
| 2026-05-14 | KIDD BRIAN F | SVP, CFO | Exercise or conversion | 4K | $94.10 | $376K | 33K |
| 2026-05-14 | Flatt Stephen Fowler | CEO | Tax withholding | 4K | $197.96 | $889K | 67K |
| 2026-05-14 | Flatt Stephen Fowler | CEO | Exercise or conversion | 1K | $90.62 | $91K | 72K |
| 2026-05-14 | Flatt Stephen Fowler | CEO | Exercise or conversion | 5K | $94.10 | $471K | 71K |
| 2026-05-06 | Trail Sandra Y. | Director | Exercise or conversion | 3K | $55.75 | $175K | 11K |
| 2026-05-05 | LAROCHE RICHARD F JR | Director | Exercise or conversion | 8K | $71.64 | $537K | 213K |
| 2026-04-30 | HASSAN EMIL E | Director | Exercise or conversion | 8K | $71.64 | $537K | 73K |
| 2026-04-22 | Dodson Vicki L | Sr.VP Patient Srvcs | Tax withholding | 3K | $173.63 | $495K | 16K |
| 2026-04-22 | Dodson Vicki L | Sr.VP Patient Srvcs | Exercise or conversion | 4K | $94.10 | $376K | 18K |
| 2026-04-09 | FLATT BEN ANDERSON SR | Senior VP & CIO | Tax withholding | 2K | $176.81 | $373K | 21K |
| 2026-04-09 | FLATT BEN ANDERSON SR | Senior VP & CIO | Tax withholding | 2K | $176.81 | $338K | 21K |
| 2026-04-09 | FLATT BEN ANDERSON SR | Senior VP & CIO | Exercise or conversion | 4K | $53.94 | $201K | 23K |
| 2026-03-16 | Dodson Vicki L | Sr.VP Patient Srvcs | Tax withholding | 2K | $164.96 | $336K | 14K |
| 2026-03-16 | Dodson Vicki L | Sr.VP Patient Srvcs | Exercise or conversion | 4K | $53.94 | $201K | 16K |
| 2026-03-12 | KIDD BRIAN F | SVP, CFO | Exercise or conversion | 2K | $53.94 | $100K | 29K |
| 2026-03-12 | Flatt Stephen Fowler | CEO | Exercise or conversion | 2K | $53.94 | $100K | 66K |
| 2026-03-09 | ABERNATHY JAMES PAUL | Director | Exercise or conversion | 3K | $55.75 | $175K | 43K |
| 2026-03-04 | Shelly Timothy J. | Sr.VP Operations | Tax withholding | 4K | $172.83 | $774K | 3K |
| 2026-03-04 | Shelly Timothy J. | Sr.VP Operations | Exercise or conversion | 4K | $90.62 | $332K | 8K |
| 2026-03-04 | Shelly Timothy J. | Sr.VP Operations | Exercise or conversion | 3K | $94.10 | $251K | 4K |
| 2026-03-04 | McCreary Josh A | Senior VP & General Counsel | Tax withholding | 3K | $172.83 | $553K | 13K |
| 2026-03-04 | McCreary Josh A | Senior VP & General Counsel | Exercise or conversion | 5K | $90.62 | $408K | 16K |
| 2026-03-04 | KIDD BRIAN F | SVP, CFO | Tax withholding | 4K | $172.83 | $682K | 27K |
| 2026-03-04 | KIDD BRIAN F | SVP, CFO | Exercise or conversion | 4K | $90.62 | $362K | 31K |
| 2026-03-04 | KIDD BRIAN F | SVP, CFO | Exercise or conversion | 2K | $53.94 | $108K | 27K |
| 2026-03-04 | FLATT BEN ANDERSON SR | Senior VP & CIO | Tax withholding | 8K | $172.83 | $1.4M | 20K |
| 2026-03-04 | FLATT BEN ANDERSON SR | Senior VP & CIO | Exercise or conversion | 5K | $90.62 | $408K | 28K |
| 2026-03-04 | FLATT BEN ANDERSON SR | Senior VP & CIO | Exercise or conversion | 4K | $94.10 | $376K | 23K |
| 2026-03-04 | FLATT BEN ANDERSON SR | Senior VP & CIO | Exercise or conversion | 4K | $53.94 | $201K | 19K |
| 2026-03-04 | Dodson Vicki L | Sr.VP Patient Srvcs | Tax withholding | 3K | $172.83 | $546K | 13K |
| 2026-03-04 | Dodson Vicki L | Sr.VP Patient Srvcs | Exercise or conversion | 5K | $90.62 | $408K | 16K |
| 2026-03-02 | Flatt Stephen Fowler | CEO | Tax withholding | 4K | $171.15 | $614K | 64K |
| 2026-03-02 | Flatt Stephen Fowler | CEO | Exercise or conversion | 5K | $90.62 | $453K | 67K |
| 2026-02-27 | Shelly Timothy J. | Sr.VP Operations | Grant | 1K | $0.00 | $0 | 1K |
| 2026-02-27 | McCreary Josh A | Senior VP & General Counsel | Grant | 1K | $0.00 | $0 | 11K |
| 2026-02-27 | KIDD BRIAN F | SVP, CFO | Grant | 2K | $0.00 | $0 | 25K |
| 2026-02-27 | Flatt Stephen Fowler | CEO | Grant | 3K | $0.00 | $0 | 62K |
| 2026-02-27 | FLATT BEN ANDERSON SR | Senior VP & CIO | Grant | 1K | $0.00 | $0 | 15K |
| 2026-02-27 | Dodson Vicki L | Sr.VP Patient Srvcs | Grant | 1K | $0.00 | $0 | 11K |
| 2026-01-15 | ABERNATHY JAMES PAUL | Director | Tax withholding | 4K | $139.01 | $519K | 40K |
| 2026-01-15 | ABERNATHY JAMES PAUL | Director | Exercise or conversion | 8K | $69.82 | $524K | 44K |
| 2026-01-01 | KIDD BRIAN F | SVP, CFO | Tax withholding | 447 | $137.09 | $61K | 24K |
| 2026-01-01 | FLATT BEN ANDERSON SR | Senior VP & CIO | Tax withholding | 403 | $137.09 | $55K | 14K |
| 2026-01-01 | Dodson Vicki L | Sr.VP Patient Srvcs | Tax withholding | 319 | $137.09 | $44K | 10K |
| 2025-12-31 | Ussery Robert Michael | President & COO | Tax withholding | 2K | $137.09 | $283K | 158K |
| 2025-12-29 | Flatt Stephen Fowler | CEO | Gift | 450 | $0.00 | $0 | 60K |
| 2025-12-23 | KIDD BRIAN F | SVP, CFO | Gift | 350 | $0.00 | $0 | 24K |
| 2025-12-17 | Ussery Robert Michael | President & COO | Gift | 40 | $0.00 | $0 | 161K |
| 2025-12-17 | Ussery Robert Michael | President & COO | Gift | 40 | $0.00 | $0 | 161K |
| 2025-12-17 | Shelly Timothy J. | Sr.VP Operations | Sell | 2K | $139.42 | $342K | 0 |
| 2025-12-17 | Ussery Robert Michael | President & COO | Gift | 45 | $0.00 | $0 | 161K |
| 2025-12-17 | Ussery Robert Michael | President & COO | Gift | 740 | $0.00 | $0 | 161K |
| 2025-12-17 | Ussery Robert Michael | President & COO | Gift | 95 | $0.00 | $0 | 161K |
| 2025-12-17 | Ussery Robert Michael | President & COO | Gift | 40 | $0.00 | $0 | 161K |
| 2025-12-12 | Flatt Stephen Fowler | CEO | Gift | 145 | $0.00 | $0 | 61K |
| 2025-12-12 | Flatt Stephen Fowler | CEO | Gift | 217 | $0.00 | $0 | 61K |
| 2025-12-01 | FLATT BEN ANDERSON SR | Senior VP & CIO | Tax withholding | 2K | $137.29 | $327K | 15K |
| 2025-12-01 | FLATT BEN ANDERSON SR | Senior VP & CIO | Exercise or conversion | 4K | $63.96 | $239K | 17K |
| 2025-11-25 | Flatt Stephen Fowler | CEO | Exercise or conversion | 2K | $53.94 | $100K | 61K |
| 2025-11-25 | HASSAN EMIL E | Director | Sell | 8K | $138.52 | $1.0M | 66K |
| 2025-11-25 | Dodson Vicki L | Sr.VP Patient Srvcs | Tax withholding | 3K | $137.95 | $433K | 11K |
| 2025-11-25 | Dodson Vicki L | Sr.VP Patient Srvcs | Exercise or conversion | 4K | $94.10 | $376K | 14K |
| 2025-11-21 | Flatt Stephen Fowler | CEO | Sell | 1K | $130.33 | $130K | 59K |
| 2025-11-12 | HASSAN EMIL E | Director | Sell | 6K | $133.00 | $732K | 73K |
| 2025-11-11 | Ussery Robert Michael | President & COO | Exercise or conversion | 5K | $94.10 | $423K | 165K |
| 2025-11-11 | Ussery Robert Michael | President & COO | Tax withholding | 4K | $132.20 | $492K | 162K |
| 2025-11-11 | Ussery Robert Michael | President & COO | Tax withholding | 2K | $132.20 | $225K | 161K |
| 2025-11-11 | Ussery Robert Michael | President & COO | Exercise or conversion | 5K | $53.94 | $243K | 162K |
| 2025-11-11 | Shelly Timothy J. | Sr.VP Operations | Tax withholding | 3K | $132.20 | $409K | 2K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for NHC worth $2.1M at the prices reported; 1 in the last 90 days worth $601K. Latest: McCreary Josh A filed on 2026-09-10 to sell 2,719 shares ($601K) from 2026-09-10.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-10 | McCreary Josh AOfficer | 3K | $601K | 0.017% | 2026-09-10 | Janney Montgomery Scott |
| 2026-05-21 | Richard F. LaRocheDirector | 8K | $1.5M | 0.048% | 2026-05-21 | UBS Financial Services Inc |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of NHC in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 11.6% of the class (1,800,345 shares), filed 2025-10-17 for an event on 2025-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-30 | 13G/Ano. 1 | The Charger Corporationparent holding company | 714K | 4.6% | 2026-09-30 |
| 2026-10-30 | 13G/Ano. 1 | First Trust Advisors L.P.investment adviser | 714K | 4.6% | 2026-09-30 |
| 2026-10-30 | 13G/Ano. 1 | First Trust Portfolios L.P.broker-dealer | 714K | 4.6% | 2026-09-30 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 794K | 5.1% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 10 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-03-12 | 13G/Ano. 1 | Morgan Stanleyparent holding company, corporation | 1.1M | 7.1% | 2025-12-31 |
| 2026-03-12 | 13G/Ano. 1 | Morgan Stanley Institutional Investment Advisors LLCinvestment adviser, corporation | 1.0M | 6.7% | 2025-12-31 |
| 2025-10-17 | 13G/Ano. 7 | BlackRock, Inc.parent holding company, parent holding company | 1.8M | 11.6% | 2025-09-30 |
13F holders
Tracked managers holding NHC at their latest 13F. JSON3 of the 30 tracked managers held NHC at their latest 13F, $70.5M in total at quarter-end prices. Renaissance Technologies is the largest at $63.3M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 300K | $63.3M | 0.09% | -36K |
| AQR Capital Management | 2026-06-30 | 27K | $5.7M | 0.00% | -3K |
| Two Sigma Investments | 2026-06-30 | 7K | $1.4M | 0.00% | -76K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) National Healthcare reported revenue of $408.0M, up 8.8% from the same quarter a year earlier, and net income of $40.3M (2.54 diluted EPS). In FY 2025 it generated $185.1M of operating cash flow and spent $14.7M on buybacks and $38.7M on dividends. As of 2026-06-30, cash was $39.2M against $0 of debt.
- Cash
- $39.2M
- Debt
- $0
- Equity
- $1.12B
- Total assets
- $1.54B
- Shares outstanding
- 15,661,395
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $408.0M | $40.3M | 9.9% | 2.54 |
| Q1 FY 2026 | 2026-03-31 | $381.8M | $35.9M | 9.4% | 2.27 |
| Q4 FY 2025derived | 2025-12-31 | $386.5M | $24.8M | 6.4% | n/a |
| Q3 FY 2025 | 2025-09-30 | $382.7M | $39.2M | 10.3% | 2.50 |
| Q2 FY 2025 | 2025-06-30 | $374.9M | $23.7M | 6.3% | 1.52 |
| Q1 FY 2025 | 2025-03-31 | $373.7M | $32.2M | 8.6% | 2.07 |
| Q4 FY 2024derived | 2024-12-31 | $369.4M | $6.1M | 1.6% | n/a |
| Q3 FY 2024 | 2024-09-30 | $340.2M | $42.8M | 12.6% | 2.73 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.52B | $120.0M | $185.1M | $36.4M | $14.7M | $38.7M |
| FY 2024 | 2024-12-31 | $1.31B | $101.9M | $107.3M | $27.6M | $13.5M | $37.0M |
| FY 2023 | 2023-12-31 | $1.14B | $66.8M | $111.2M | $27.9M | $2.5M | $35.6M |
| FY 2022 | 2022-12-31 | $1.09B | $22.4M | $8.7M | $30.2M | $9.9M | $34.6M |
| FY 2021 | 2021-12-31 | $1.07B | $138.6M | $62.4M | $39.4M | $836K | $32.0M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-03 from the cover page.
What this page is
National Healthcare in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows National Healthcare (NHC), SEC CIK 1047335, listed on NYSE, classified by the SEC as services-skilled nursing care facilities. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-28.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-10.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-30.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-11.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-22.JSON and CSV
- Company record
- EDGAR filing index for CIK 1047335Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-skilled nursing care facilities
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
Datasets
Frequently Asked Questions
How much of NHC is sold short?
755,039 shares were held short at the 2026-10-15 settlement, 8.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is NHC's daily short volume?
On 2026-11-02, 45,156 of the 64,015 NHC shares reported to FINRA were sold short, 70.5% of the day's reported volume. Short volume is a flow for one day, not a position.
Does NHC have fails to deliver?
The SEC's latest file shows 1,258 NHC shares failed to deliver at settlement 2026-09-28. Fails are reported per settlement date and published twice a month with a lag.
Are NHC insiders buying or selling?
Insiders at NHC reported 15 open-market sells worth $5.6M in the last 90 days and no open-market buys. Latest filing: Dodson Vicki L (Sr.VP Patient Srvcs) on 2026-09-22.
Have NHC insiders filed to sell?
2 Form 144 notices on file for NHC worth $2.1M at the prices reported; 1 in the last 90 days worth $601K. Latest: McCreary Josh A filed on 2026-09-10 to sell 2,719 shares ($601K) from 2026-09-10.
Who owns 5% or more of NHC?
4 holders report 5% or more of NHC in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 11.6% of the class (1,800,345 shares), filed 2025-10-17 for an event on 2025-09-30.
What did NHC report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) National Healthcare reported revenue of $408.0M, up 8.8% from the same quarter a year earlier, and net income of $40.3M (2.54 diluted EPS). In FY 2025 it generated $185.1M of operating cash flow and spent $14.7M on buybacks and $38.7M on dividends. As of 2026-06-30, cash was $39.2M against $0 of debt.
Which tracked 13F managers own NHC?
3 of the 30 tracked 13F managers held NHC shares at their latest filing, $70.5M in all. The largest: Renaissance Technologies (300K shares, $63.3M), Cliff Asness's AQR Capital Management (27K shares, $5.7M), Two Sigma Investments (7K shares, $1.4M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.